Shopping Cart
Remove All
Your shopping cart is currently empty
CPN-219 is a next-generation hexapeptidic NMUR2 agonist that selectively and dose-dependently activates NMUR2, exhibiting an EC50 value of 2.2 nM [1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | CPN-219 is a next-generation hexapeptidic NMUR2 agonist that selectively and dose-dependently activates NMUR2, exhibiting an EC50 value of 2.2 nM [1]. |
| In vivo | In an animal model using ddY mice [1], a compound was administered to the nasal cavity at dosages of 250, 100, and 25 µg/mouse, resulting in a dose-dependent suppression of body weight gain. |
| Molecular Weight | 849.08 |
| Formula | C40H72N12O8 |
| Cas No. | 2240202-02-0 |
| Sequence | {3-Cyclohexylpropionyl}-Leu-Leu-{Dbu}-Pro-Arg-Asn-NH2 |
| Sequence Short | {3-Cyclohexylpropionyl}-LL-{Dbu}-PRN-NH2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.